Viewing nowCombinationDucarb Plus Tablet 60/5/25 mg
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202202455 · Approved 2022.06.10 · Insurance code 641907950
Treatment of essential hypertension
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by existing treatments, through a combination therapy of Pimasartan Potassium and Amlodipine. This combination agent dilates blood vessels, lowers blood pressure, and reduces the burden on the heart. Therefore, it is effective for managing hypertension and also helps in preventing cardiovascular diseases. Regular use promotes stable blood pressure control and improves health.
Take 1 tablet of this medication once daily with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before starting this medication, it is recommended to adjust the dose using the individual components (fimasartan potassium and amlodipine as monotherapy or combination therapy). For patients whose blood pressure is not controlled with fimasartan potassium/amlodipine combination therapy, administer this medication at 30/5/12.5 mg and adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The maximum dose of this medication is 60/10/25 mg. Patients taking a fimasartan potassium/amlodipine combination product together with hydrochlorothiazide as a single agent may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience.
This medication poses a serious risk of harm or death to the fetus and newborn when taken during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. Patients with allergies to this drug or similar medications, those with severely impaired liver or kidney function, pregnant or breastfeeding women, and patients with certain cardiovascular diseases should not take this medication. Special care should be taken when administering this medication to patients with reduced blood volume, weak kidney function, or elderly patients, as there is a risk of hypotension or kidney function worsening. While taking this medication, side effects such as dizziness, headaches, and dyspepsia may occur, and rarely, abnormal reactions like changes in blood test results or skin rashes may occur. As this medication lowers blood pressure, hypotension symptoms may appear when starting treatment or increasing the dosage, so the patient's condition should be closely monitored. There is a risk of elevated potassium levels; thus, patients with heart failure or kidney disease should have their serum potassium levels checked regularly. This medication may interact with other antihypertensive drugs, diuretics, or certain anti-inflammatory medications, so it's crucial to inform healthcare providers about any other medications being taken. Pregnant or breastfeeding women should not take this drug, and those who are breastfeeding should carefully consider whether to take it. Safety and efficacy in children and adolescents under 18 years old have not been established, so it is advisable not to use it in these populations. For elderly patients, starting at a low dose and gradually increasing the dose is considered safer, with special attention paid to dehydration or electrolyte imbalances. In the event of overdose, symptoms such as low blood pressure, palpitations, and dizziness may occur; seek medical attention immediately if any abnormal symptoms occur. This medication should be stored out of reach of children and should not be transferred to other containers.
Dizziness, headache, bone necrosis, hypotension, palpitations, dyspepsia, sensory impairment, increased creatine phosphokinase (CPK) in blood, confusion, rectal bleeding, dental caries, duodenitis, gastritis, hemorrhoids, stomatitis, increased alanine aminotransferase (ALT), increased blood sugar, edema, peripheral edema, cystitis, nasopharyngitis, hyperuricemia, hypokalemia, hyponatremia, muscle cramps, increased creatine phosphokinase (CPK) in blood, increased alanine aminotransferase (ALT), increased blood sugar, dizziness, orthostatic dizziness, facial edema, peripheral edema, urination disorders, insomnia, flushing, sensory abnormalities, tremor, spinal stenosis, gastroesophageal reflux, constipation, gastroenteritis, rash, arthralgia, arthritis, osteoporosis, muscle weakness, edema, peripheral edema, pharyngitis, phlegm, bronchitis, visual disturbances, retinal disease, floaters, frequent urination, exacerbation of chronic renal failure, shingles, insomnia, depression, tachycardia, asthenia, foreign body sensation, cough, muscle contraction, musculoskeletal rigidity, itching, localized urticaria, facial flushing, flushing, erectile dysfunction, fatigue, drowsiness, emotional blunting, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, arrhythmia, temporary blurred vision, jaundice, hepatitis, acute cholecystitis, necrotizing vasculitis, dyspnea, rash, urticaria, facial flushing, photosensitivity, anaphylaxis, increased BUN and creatinine, acute kidney failure, interstitial nephritis, lethargy, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, hypercalcemia, muscle cramps, sensory abnormalities, increased blood pressure, decreased blood pressure, chest palpitations, bradycardia, reflex tachycardia, shock, decreased plasma volume, dehydration, hypotension, orthostatic hypotension, vasculitis, tension increase, peripheral neuropathy, syncope, taste abnormalities, tremor, extrapyramidal disorder, gynecomastia, changes in bowel habits, dry mouth, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, dyspnea, rhinitis, hair loss, sweating, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urination disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, anorexia, nausea, vomiting, thirst, abdominal discomfort, constipation, abdominal colic, pancreatitis, diarrhea, sialadenitis, dry mouth, abdominal pain, dizziness, headache, fatigue, drowsiness, emotional blunting, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, palpitations, orthostatic hypotension, arrhythmia, temporary blurred vision, jaundice, hepatitis, acute cholecystitis, necrotizing vasculitis, dyspnea, rash, urticaria, facial flushing, photosensitivity, anaphylaxis, increased BUN and creatinine, acute kidney failure, interstitial nephritis, lethargy, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, hypercalcemia, muscle cramps, sensory abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness and safety of the medication.
White rectangular film-coated tablet
30 tablets/box[(10 tablets/PTP x 3)], 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg +1 more
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg +1 more
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.